Ross O A, Whittle A J, Cobb S A, Hulihan M M, Lincoln S J, Toft M, Farrer M J, Dickson D W
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Neuropathol Appl Neurobiol. 2006 Feb;32(1):23-5. doi: 10.1111/j.1365-2990.2006.00693.x.
Mutation of the LRRK2 gene has been associated with autosomal dominant parkinsonism. An R1441C pathogenic substitution was identified in Family D, a large Western Nebraskan kindred, with four members demonstrating pleomorphic pathology at autopsy. One member of this family displayed tau pathology suggestive of progressive supranuclear palsy (PSP). To evaluate the influence of mutation at the R1441 residue in this disorder we screened a series of 242 pathologically confirmed PSP cases. No evidence was found for the presence of a mutation at this codon in our series. These data would suggest that this Lrrk2 variant does not contribute in susceptibility to PSP.
LRRK2基因的突变与常染色体显性帕金森病有关。在一个来自内布拉斯加州西部的大家族(家族D)中,发现了一种R1441C致病性替代突变,该家族中有四名成员在尸检时表现出多形性病理特征。这个家族的一名成员表现出tau蛋白病理特征,提示进行性核上性麻痹(PSP)。为了评估该疾病中R1441位点突变的影响,我们筛查了一系列242例经病理证实的PSP病例。在我们的系列研究中,未发现该密码子存在突变的证据。这些数据表明,这种Lrrk2变体对PSP的易感性没有影响。